Companies To Watch Endevica Bio
Endevica Bio is developing a new treatment for cachexia, a severe wasting disease critical to patients’ survival in cancer and other conditions.
Stay updated with breaking news from Wayne Koberstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Endevica Bio is developing a new treatment for cachexia, a severe wasting disease critical to patients’ survival in cancer and other conditions.
As Shoreline’s chairman, CEO, and cofounder, Dr. Kleanthis Xanthopoulos draws on his experience of several decades, starting and running...
Can bioinformatics help biopharma companies manage their expectations and limit their risk in drug R&D? Ben Zeskind, a CEO who has built and bet...
Five leading biopharma executives discuss the perils of political influence over the FDA and CDC and why every member of the industry should care.
Graphite Bio focuses on precise repair of genes that cause sickness, starting with Sickle Cell Disease.